Arena Investors LP
CIK
1699673
Location
NEW YORK, NY
Portfolio Value
Micro
$78,020,150
Diversification
Highly concentrated
Filing Date
Global Rank
#5,421
/ 7,299
▲ 1463
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+5.8%
Period ended 1 year ago
Filed Aug 14, 2024 · 1y
8 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+111.0%
SPY
+76.5%
Annualised alpha
+7.4%
Max drawdown
−22.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Jun 30, 2024 · Δ vs Sep 30, 2023Top Position
99.7%
−0.3 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
9,947
Highly concentrated−53
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 99.7% | $77,814,650 |
| Healthcare | 0.3% | $205,500 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| OKE | Oneok Inc /New/ | 6 | $380 | |
| No positions match the current search. | ||||
2 positions ·
$78,020,150 total
· as of Jun 30, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
NEW | 162,415 | $77,814,650 | 99.74% | |
| ELTX |
Elicio Therapeutics, Inc.
Healthcare
|
NEW | 50,000 | $205,500 | 0.26% |